Drug information for THYROGEN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 1.1MG/VIAL Prescription  (Reference Drug) THYROTROPIN ALFA Glycoprotein Hormones, alpha Subunit GENZYME 20898
2008-08-29 Label

2008-08-19 Letter

2008-01-09 Letter

2007-12-27 Label

2006-01-30 Letter

2006-01-25 Label

2004-04-05 Label

2004-03-16 Letter

2001-06-19 Review

1998-11-30 Label

1998-11-30 Letter

Drug Adverse Effects information for THYROGEN

Role code Indications Reaction # Reports
PS DIAGNOSTIC PROCEDURE DECREASED APPETITE 1
PS DIAGNOSTIC PROCEDURE HYPOACUSIS 1
PS DIAGNOSTIC PROCEDURE MOBILITY DECREASED 1
PS DIAGNOSTIC PROCEDURE NAUSEA 1
PS DIAGNOSTIC PROCEDURE SPEECH DISORDER 1
PS DIAGNOSTIC PROCEDURE VISUAL IMPAIRMENT 1
PS DIAGNOSTIC PROCEDURE VOMITING 1
PS DIAGNOSTIC PROCEDURE WHITE BLOOD CELL DISORDER 1
PS THYROID CANCER ANAEMIA 1
PS THYROID CANCER DECREASED APPETITE 1
PS THYROID CANCER DYSPNOEA 2
PS THYROID CANCER HEARING IMPAIRED 1
PS THYROID CANCER LUNG CONSOLIDATION 2
PS THYROID CANCER MOVEMENT DISORDER 1
PS THYROID CANCER NAUSEA 1
PS THYROID CANCER OXYGEN SATURATION DECREASED 2
PS THYROID CANCER PAIN 2
PS THYROID CANCER SPEECH DISORDER 1
PS THYROID CANCER STRIDOR 2
PS THYROID CANCER TRACHEAL DISORDER 2
PS THYROID CANCER VISUAL ACUITY REDUCED 1
PS THYROID CANCER VOMITING 1
PS THYROID CANCER WHITE BLOOD CELL COUNT ABNORMAL 1
Ads by Google